Cardiac MRI Matches SPECT Accuracy While Eliminating Radiation Risk
Cardiac MRI is proving its place as a powerful, radiation-free alternative to SPECT in diagnosing coronary artery disease.
News
Brensocatib faces ICER spotlight with strong case for clinical and economic value
ICER pegs an ~$88K benchmark for brensocatib and spotlights evidence gaps shaping NCFB access.
Novo’s unsolicited bid for Metsera challenges Pfizer pact
Novo’s unsolicited Metsera bid could upend Pfizer pact and reshape the GLP-1 race.
Reimbursement Series: CMS and Europe Reimbursement Pathway Accelerates Innovation
In a transformative week for market access, the CMS and Europe reimbursement pathway expansion delivered several pivotal coverage and pricing decisions reshaping patient access across cardiovascular, hepatic, and oncology therapies. From CMS’s national determinations on breakthrough devices to European HTA approvals in rare disease and cancer, these developments underscore a growing transatlantic alignment between regulators … Read more
New Proposal Calls for Funeral Reimbursement to Boost U.S. Organ Donation
Funeral reimbursement could transform U.S. organ donation access and equity.
Evernorth Secures Breakthrough Pricing Shift in Drug Access
Evernorth’s pricing model overhaul transforms drug access and reimbursement dynamics.
Sprouts Launches Bold Lawsuit Challenging Insulin Pricing
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.
Baird Medical Secures Pivotal Reimbursement Win for MWA
Successful reimbursement milestone strengthens device adoption and access strategy.
UK Government Unlocks Game-Changing Drug Pricing Strategy
UK braces as drug pricing shifts dramatically in market access landscape.
Regeneron Unlocks Game-Changing Multispecific Antibody Pact
Regeneron boosts its pipeline with multispecific platform for disease innovation.